Ad is loading...
MENU
PHAT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Phathom Pharmaceuticals (PHAT) Ownership - Who owns Phathom Pharmaceuticals?
Profile
Industry
N/A
Address
100 Campus Drive
Phone
+1 877 742-8466
Employees
452
Web
https://www.phathompharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
600.35M
P/E Ratio
N/A
Total Cash
276.24M
Projected Growth
N/A
Total Debt
175.28M
Revenue
9.92M
Risk (Beta)
0.52
Dividend Yield
N/A
Total Cash/Share
4.04
Total Debt/Equity
N/A
Revenue/Share
0.44 USD as % of share price
Fundamentals
PHAT
Capitalization
600M
P/E Ratio
N/A
Risk (Beta)
0.52
Dividend Yield
N/A
Total Cash
276M
Total Cash/Share
4.04
Total Debt
175M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.44%
Revenue
9.92M
ROE
N/A
Book Value
-233.83M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-5.18
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
6.48
Current Revenue Per Employee
65392.86
Dividends Per Share - Security
N/A
EBITDA
-238.33M
Float
N/A
Float - Current
N/A
Gross Income Margin
81.21
Revenue To Assets
-101.68
Shares Held By Institutions
893M
Shares Outstanding - Current
68.4M
Total Liabilities
553M
Total Volume MTD
N/A
Value
-1
Gain YTD
-3.834
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company, which focuses on the development and commercialization of novel treatments for gastrointestinal diseases and disorders
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
100 Campus Drive
Phone
+1 877 742-8466
Employees
452
Web
https://www.phathompharma.com